Gradient Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-80
| Closed | -$6.59K | – | 414 |
|
|
2024
Q2 | $6.59K | Hold |
80
| – | – | ﹤0.01% | 808 |
|
|
2024
Q1 | $6.99K | Sell |
80
-8
| -9% | -$699 | ﹤0.01% | 681 |
|
|
2023
Q4 | $8.49K | Hold |
88
| – | – | ﹤0.01% | 873 |
|
|
2023
Q3 | $7.79K | Hold |
88
| – | – | ﹤0.01% | 852 |
|
|
2023
Q2 | $7.63K | Buy |
88
+8
| +10% | +$693 | ﹤0.01% | 863 |
|
|
2023
Q1 | $7.78K | Hold |
80
| – | – | ﹤0.01% | 862 |
|
|
2022
Q4 | $8.28K | Hold |
80
| – | – | ﹤0.01% | 847 |
|
|
2022
Q3 | $7K | Hold |
80
| – | – | ﹤0.01% | 868 |
|
|
2022
Q2 | $7K | Hold |
80
| – | – | ﹤0.01% | 831 |
|
|
2022
Q1 | $6K | Hold |
80
| – | – | ﹤0.01% | 854 |
|
|
2021
Q4 | $7K | Hold |
80
| – | – | ﹤0.01% | 862 |
|
|
2021
Q3 | $6K | Sell |
80
-33
| -29% | -$2.48K | ﹤0.01% | 849 |
|
|
2021
Q2 | $9K | Sell |
113
-19
| -14% | -$1.51K | ﹤0.01% | 774 |
|
|
2021
Q1 | $10K | Sell |
132
-56,157
| -100% | -$4.25M | ﹤0.01% | 755 |
|
|
2020
Q4 | $4.28M | Sell |
56,289
-621
| -1% | -$47.2K | 0.18% | 117 |
|
|
2020
Q3 | $4.33M | Buy |
56,910
+9,898
| +21% | +$753K | 0.18% | 117 |
|
|
2020
Q2 | $5.8M | Buy |
47,012
+833
| +2% | +$103K | 0.26% | 93 |
|
|
2020
Q1 | $3.9M | Buy |
46,179
+4,008
| +10% | +$339K | 0.21% | 99 |
|
|
2019
Q4 | $3.57M | Buy |
42,171
+4,702
| +13% | +$398K | 0.16% | 103 |
|
|
2019
Q3 | $2.53M | Buy |
37,469
+8,361
| +29% | +$563K | 0.12% | 116 |
|
|
2019
Q2 | $2.49M | Buy |
29,108
+26,297
| +936% | +$2.25M | 0.13% | 108 |
|
|
2019
Q1 | $250K | Buy |
+2,811
| New | +$250K | 0.02% | 235 |
|
|
2018
Q3 | – | Sell |
-300
| Closed | -$28K | – | 981 |
|
|
2018
Q2 | $28K | Buy |
+300
| New | +$28K | ﹤0.01% | 424 |
|